Abstract 1490P
Background
Cancer is a debilitating disease that affects both patients and their caregivers. The diagnosis and treatment of cancer could affect the quality life of the patient and their family. Patients undergoing chemotherapy experience physical and emotional symptoms that affect their quality of life. Some of them experienced difficulty sleeping, depression and poor quality of life. Caregivers of cancer patients may have to cope with a variety of physical, social, and economic problems during the caregiving process. Caregivers experienced caregiver strain while providing care for the patient. The caregiver strain influences the quality of care and thus the quality of life of the patient. Hence, this study aims to determine the health-related quality of life of cancer patients on chemotherapy and its relationship with caregiver strain.
Methods
A cross sectional analytical study was conducted among cancer patients and their caregiver at the Bataan General Hospital and Medical Center. The EORTC core quality of life questionnaire (QLQ-C30) and modified caregiver strain index (MCSI) questionnaires were administered to assess HRQoL and caregiver strain respectively. Descriptive statistics, Pearson correlation and Spearman rank were performed for analysis of quality-of-life parameters and caregiver strain.
Results
A total of 145 cancer patient-caregiver dyads were included in this study. The median global health status among cancer patients was 75 (66.67 to 91.67) suggesting an optimistic view of overall health and quality of life. The median MCSI score was 19 (14 to 24) indicating a moderate to high level of strain. The relationship between health-related quality of life and caregiver strain showed minimal to no meaningful relationship.
Conclusions
Cancer patients generally exhibit satisfactory to high functioning across physical, role, and cognitive functions. The caregiving role, irrespective of the patient's condition, carries intrinsic challenges. Although the relationship between the HRQoL of patients and caregiver strain was very weak, both are important and functions independently.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1481P - A case-control study of drug-eluting microspheres and blank microspheres in bronchial artery embolization for hemoptysis in non-small cell lung cancer
Presenter: Tongguo Si
Session: Poster session 10
1482P - Percutaneous transhepatic biliary drainage (PTBD) for palliation of jaundice in patients of unresectable/disseminated carcinoma gall bladder with hilar block: Is it a worthwhile enterprise?
Presenter: Saurabh Galodha
Session: Poster session 10
1484P - Inflammatory patterns of ascites in patients with solid tumors
Presenter: Julia Berger
Session: Poster session 10
1485P - Mitigating symptom clusters of patients with metastatic cancer through a remote physical exercise program (EXIO)
Presenter: Paulo Bergerot
Session: Poster session 10
1486P - A personalized rehabilitation pilot program for improving QOL of unresectable metastatic lung cancer patients
Presenter: Shani Shilo
Session: Poster session 10
1487P - Telemonitoring system effectiveness for alleviating cancer pain in patients with advanced cancer
Presenter: Shiori Yoshida
Session: Poster session 10
1488P - Use of mobile app “SUPPORT+” to enhance community palliative care in advanced cancer patients: A feasibility study
Presenter: Wendy Chan
Session: Poster session 10
1489P - Factors influencing adherence to electronic patient-reported outcomes in palliative cancer care
Presenter: Sarah Gomes
Session: Poster session 10
1491P - Palliative care of E-warm model for driver-gene-negative non-small cell lung cancer patients: A single-center randomized controlled trial
Presenter: Junhui Zhang
Session: Poster session 10
Resources:
Abstract